ZA872189B - New optically active compound - Google Patents

New optically active compound

Info

Publication number
ZA872189B
ZA872189B ZA872189A ZA872189A ZA872189B ZA 872189 B ZA872189 B ZA 872189B ZA 872189 A ZA872189 A ZA 872189A ZA 872189 A ZA872189 A ZA 872189A ZA 872189 B ZA872189 B ZA 872189B
Authority
ZA
South Africa
Prior art keywords
active compound
optically active
new optically
new
compound
Prior art date
Application number
ZA872189A
Other languages
English (en)
Inventor
Hermann Amschler
Amschler Hermann
Manfrid Eltze
Eltze Manfrid
Dieter Flockerzi
Flockerzi Dieter
Kurt Klemm
Klemm Kurt
Bernhard Kohl
Kohl Bernhard
Norbert Kolassa
Kolassa Norbert
Karl Sanders
Sanders Karl
Christian Schudt
Schudt Christian
Wolf-Ruediger Ulrich
Ulrich Wolf-Ruediger
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of ZA872189B publication Critical patent/ZA872189B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA872189A 1986-03-27 1987-03-25 New optically active compound ZA872189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH126386 1986-03-27

Publications (1)

Publication Number Publication Date
ZA872189B true ZA872189B (en) 1987-11-25

Family

ID=4206306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872189A ZA872189B (en) 1986-03-27 1987-03-25 New optically active compound

Country Status (12)

Country Link
EP (1) EP0240828A1 (da)
JP (1) JPS62270528A (da)
KR (1) KR870008872A (da)
CN (1) CN87102402A (da)
AU (1) AU574604B2 (da)
DK (1) DK142287A (da)
FI (1) FI871327A (da)
HU (1) HU196791B (da)
NO (1) NO871284L (da)
NZ (1) NZ219779A (da)
PT (1) PT84566B (da)
ZA (1) ZA872189B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
AU638205B2 (en) * 1988-02-19 1993-06-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically pure r-(-)-niguldipine and its derivatives for treating tumorous diseases
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
US6015819A (en) 1992-11-13 2000-01-18 Synaptic Pharmaceutical Corporation Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
FI83957C (fi) * 1984-09-28 1991-09-25 Byk Gulden Lomberg Chem Fab Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara diarylfoereningar.
DK114587A (da) * 1986-03-12 1987-09-13 Byk Gulden Lomberg Chem Fab Monocycliske esterderivater

Also Published As

Publication number Publication date
FI871327A (fi) 1987-09-28
FI871327A0 (fi) 1987-03-26
CN87102402A (zh) 1987-10-07
KR870008872A (ko) 1987-10-21
AU7052587A (en) 1987-12-10
JPS62270528A (ja) 1987-11-24
NO871284L (no) 1987-09-28
HUT43588A (en) 1987-11-30
PT84566A (de) 1987-04-01
DK142287A (da) 1987-09-28
DK142287D0 (da) 1987-03-19
PT84566B (pt) 1989-11-30
NO871284D0 (no) 1987-03-26
HU196791B (en) 1989-01-30
EP0240828A1 (de) 1987-10-14
AU574604B2 (en) 1988-07-07
NZ219779A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
EG18338A (en) New pharmacologycally active compounds
GB8625185D0 (en) Active compounds
EP0249078A3 (en) Optically active adsorbents
EP0255962A3 (en) Optically active mesomorphic compound
GB8613786D0 (en) Active compounds
GB8621870D0 (en) Active compounds
ZA872189B (en) New optically active compound
AU1541188A (en) New optically active compounds
GB8610911D0 (en) Active compounds
EP0243734A3 (en) Optically active hydantoin
GB8714806D0 (en) Compound
IE870779L (en) Optically active compounds
GB8630626D0 (en) Active compounds
GB8603177D0 (en) Active compounds
GB8603174D0 (en) Active compounds
GB8616031D0 (en) Active compounds
GB8630631D0 (en) Active compounds
GB8618836D0 (en) Active compounds
GB8623768D0 (en) Active compounds
GB8603173D0 (en) Active compounds
GB8630630D0 (en) Active compounds
GB8625186D0 (en) Active compounds
GB8629210D0 (en) Active compounds
GB8629233D0 (en) Active compounds
GB8610912D0 (en) Active compounds